Storia in 1 fonti

QIAGEN and NVIDIA partner on AI drug discovery

QIAGEN’s Digital Insights bioinformatics division is set to integrate NVIDIA’s accelerated computing and the BioNeMo platform to enhance AI-driven drug discovery.

Raccontata da

pharmaceutical-technology.com

mercoledì 20 maggio 2026·pharmaceutical-technology.com
QIAGEN and NVIDIA partner on AI drug discovery
QIAGEN’s Digital Insights bioinformatics division is set to integrate NVIDIA’s accelerated computing and the BioNeMo platform to enhance AI-driven drug discovery.